Drug recall · July 4, 2012
Levothroid recall
Why: Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01. Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
- Lots / codes
Lot 1087589
- Quantity
- 19,166 bottles
- Company
- Lloyd Inc, Shenandoah, IA
- Distribution
- Nationwide and PR.
- Initiated
- February 3, 2012 · Voluntary: Firm initiated
- Classified
- June 22, 2012
- Reported
- July 4, 2012
- Ended
- July 30, 2013
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.